Delivery Order SPE2DB20D1004-SPE2DB24FF5N5
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for 4,564,436,405 units of Advair HFA 115-21 MCG Inhaler 12GM, a specialty medication, with a ceiling value of $1,646.14. This delivery order...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,444.41 delivery order is for the supply of Advair 250-50 Diskus, a respiratory medication, with a period of performance through March 16, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $1,006.17, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of Advair 250-50 Diskus 60s, a pharmaceutical product, to support military healthcare...
- This federal contract award, valued at $2,148.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Advair 250-50 Diskus 60S, a prescription medication, with a period of performance through January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award, valued at $8,028.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.26 firm fixed-price delivery order is for the supply of ADVAIR 250-50 DISKUS 60S, a respiratory medication, to support military healthcare programs. The contract has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,090.13, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract is for the delivery of Advair 500-50 Diskus medication, a pharmaceutical product used to treat respiratory conditions. This award is not designated with any set-aside requirements,...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,074.36 firm fixed-price delivery order covers the supply of 4566778292 ADVAIR 250-50 DISKUS 60S, with a period of performance through December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,034.44 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The IDC with the DLA, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to supply a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF5N5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a $999,999,999 Indefinite Delivery Contract (IDC) to provide a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for Advair 250-50 Diskus 60s, a respiratory medication, with a ceiling value of $2,419.57 and a completion date of March 7, 2024. This contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen, the prime contractor, has a significant presence as a vendor for federal healthcare programs, particularly within the military and veterans' health systems, delivering a comprehensive portfolio of pharmaceuticals, medical devices, and other critical medical commodities across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/6/24 |